HK$31.74
1.15%
Hong Kong, Oct 16, 04:08 pm HKT. Closed.
ISIN
KYG549581067
Symbol
3692
Index

Hansoh Pharmaceutical Group Company Target price 2026 - Analyst rating & recommendation

Hansoh Pharmaceutical Group Company Classifications & Recommendation

Buy
93%
Hold
7%

Hansoh Pharmaceutical Group Company Price Target

Target Price HK$46.92
Price HK$31.74
Potential
Number of Estimates 25
25 Analysts have issued a price target Hansoh Pharmaceutical Group Company 2027 . The average Hansoh Pharmaceutical Group Company target price is HK$46.92. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 29 analysts: 27 Analysts recommend Hansoh Pharmaceutical Group Company to buy, 2 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Hansoh Pharmaceutical Group Company stock has an average upside potential 2027 of . Most analysts recommend the Hansoh Pharmaceutical Group Company stock at Purchase.

Sales and Margin forecast 2026, 2027 to 2033

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Dec '25 2026
Estimates
Revenue Billion HK$ ??? ???
??? ???
EBITDA Margin ??? ???
??? ???
Net Margin ??? ???
??? ???

26 Analysts have issued a sales forecast Hansoh Pharmaceutical Group Company 2026 . The average Hansoh Pharmaceutical Group Company sales estimate is

. This is than the revenue of the last 12 months(TTM). The highest sales forecast is , the lowest is .

This results in the following potential growth metrics:

Revenue Estimates

2025 HK$17.6b 22.57%
2026
2027
2028
2029
2030
2031
2032
2033

26 Hansoh Pharmaceutical Group Company Analysts have issued a net profit forecast 2026. The average Hansoh Pharmaceutical Group Company net profit estimate is

. This is than the net profit for the last 12 months(TTM). The highest net profit forecast is , the lowest is .

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 HK$6.5b 27.07%
2026
2027
2028
2029
2030
2031
2032
2033

Net Margin

2025 36.97% 3.67%
2026
2027
2028
2029
2030
2031
2032
2033

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Dec '25 2026
Estimates
Earnings Per Share HK$ ??? ???
??? ???
P/E ???
EV/Sales ???

26 Analysts have issued a Hansoh Pharmaceutical Group Company forecast for earnings per share. The average Hansoh Pharmaceutical Group Company EPS is

. This is than earnings per share in the financial year 2025. The highest EPS forecast is , the lowest is .

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 HK$1.09 26.74%
2026
2027
2028
2029
2030
2031
2032
2033

P/E ratio

Current 24.14 41.35%
2026
2027
2028
2029
2030
2031
2032
2033

Based on analysts' sales estimates for 2026, the Hansoh Pharmaceutical Group Company stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 7.86 41.82%
2026
2027
2028
2029
2030
2031
2032
2033

P/S ratio

Current 9.95 36.08%
2026
2027
2028
2029
2030
2031
2032
2033

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today